| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $5.2M | — | +100.2% |
| SG&A Expense | $518K | — | -23.9% |
| Operating Income | -$5.7M | — | -74.4% |
| Net Income | -$5.7M | — | -73.6% |
| EPS (Basic) | -$0.39 | — | -56.0% |
| EPS (Diluted) | -$0.39 | — | -56.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $10.5M | +70.0% | — |
| Total Assets | $10.5M | +70.0% | +281.9% |
| Current Liabilities | $5.2M | -10.1% | +263.9% |
| Total Liabilities | $5.2M | -10.1% | +263.9% |
| Stockholders' Equity | $5.3M | +1392.1% | +301.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.7M | — | -156.3% |
| Financing Cash Flow | $9.0M | — | +1733.8% |